The impact of age on survival in ovarian cancer: treatment perspectives

​Older women with ovarian cancer have a poorer survival rate than younger women. We want to study why this is so and how we can improve treatment.

​A research project by Anne Weng Ekmann-Gade

Studies have shown deficiencies in the treatment of older women with ovarian cancer compared to younger women.


We explore if older women are under-treated. We study the surgery, postoperative care, complications and chemotherapy treatment.


Our goal is to improve both survival and quality of life for older women with ovarian cancer.

The older population in Denmark is growing. Increasing age is directly associated with increasing rates of cancer diagnosis. This implies a rise in the older female population affected by ovarian cancer which is a disease of the elderly with almost half of patients aged 70 years or older.

Several studies have shown deficiencies in the treatment of older compared to younger women. It seems that older women are less likely to be offered standard treatment. At the same time studies disagree to whether age itself is a prognostic factor.

We explore if older women are under-treated compared to younger women. We aim to study both the surgery, postoperative care, postoperative complications and treatment with chemotherapy.

This project will provide unique knowledge of the treatment patterns in older women with ovarian cancer. Expectantly, we will identify factors that can improve the treatment and subsequent care, and the goal is to improve both survival and quality of life for older women with ovarian cancer.










Responsible editor